Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southeastern Gynecologic Oncology (SEGO) is a premier medical practice and clinical research center specializing in the treatment of gynecologic malignancies, including ovarian, uterine, and cervical cancers. Based in Atlanta, Georgia, the practice is a key affiliate of the Northside Hospital Cancer Institute, providing patients with access to advanced surgical techniques and personalized medical oncology. SEGO is distinguished by its robust clinical research program, which has participated in numerous pivotal trials leading to the FDA approval of breakthrough therapies. Led by a team of highly experienced surgeons and oncologists, the practice offers comprehensive care that integrates the latest scientific advancements with a patient-centered approach. SEGO's commitment to research is further evidenced by its close collaboration with the Ovarian Cancer Institute to develop novel diagnostic and therapeutic strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southeastern Gynecologic Oncology.